Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E14.82 EPS (ttm)12.60 Insider Own0.10% Shs Outstand639.58M Perf Week-2.37%
Market Cap119.41B Forward P/E12.48 EPS next Y14.95 Insider Trans-3.89% Shs Float620.90M Perf Month0.65%
Income8.39B PEG7.41 EPS next Q3.49 Inst Own81.20% Short Float1.75% Perf Quarter0.65%
Sales23.75B P/S5.03 EPS this Y14.80% Inst Trans-0.64% Short Ratio3.47 Perf Half Y-8.12%
Book/sh19.62 P/B9.52 EPS next Y6.23% ROA12.30% Target Price207.33 Perf Year2.81%
Cash/sh45.82 P/C4.07 EPS next 5Y2.00% ROE58.50% 52W Range163.31 - 210.19 Perf YTD-4.09%
Dividend5.80 P/FCF16.94 EPS past 5Y13.70% ROI19.60% 52W High-11.18% Beta1.20
Dividend %3.11% Quick Ratio2.60 Sales past 5Y4.90% Gross Margin82.70% 52W Low14.32% ATR3.16
Employees21500 Current Ratio2.80 Sales Q/Q7.40% Oper. Margin43.20% RSI (14)43.12 Volatility1.76% 1.67%
OptionableYes Debt/Eq2.71 EPS Q/Q18.80% Profit Margin35.30% Rel Volume0.99 Prev Close191.89
ShortableYes LT Debt/Eq2.36 EarningsApr 30 AMC Payout41.60% Avg Volume3.13M Price186.70
Recom2.30 SMA20-0.81% SMA50-2.24% SMA200-3.60% Volume3,115,239 Change-2.70%
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Mar-22-19 10:20AM  Biogen Stock Fell Too Far on Unfortunate News InvestorPlace
Mar-21-19 07:51AM  The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering Benzinga
07:12AM  9 High-Margin Stocks Seen Leading in Fed's New Dovish Era Investopedia
Mar-20-19 04:51PM  Here's Why Cytokinetics Stock Jumped Today Motley Fool
08:30AM  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis PR Newswire
08:30AM  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis GlobeNewswire
Mar-18-19 06:59PM  Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent Zacks
09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-17-19 07:31AM  Better Buy: Amgen vs. Gilead Sciences Motley Fool
Mar-15-19 04:25PM  Stocks Close Up on Signs of Progress in U.S.-China Trade Talks, Boeing Higher TheStreet.com
04:24PM  Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients? Investor's Business Daily
04:04PM  Roche Gets Approval for Label Expansion of MabThera in Europe Zacks
04:00PM  Amgen Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke PR Newswire
Mar-14-19 10:36AM  Roche Receives EC Approval for Label Expansion of Hemlibra Zacks
05:01AM  Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades Investopedia
Mar-13-19 08:37AM  FDA medical adviser: 'Congress is owned by pharma' Yahoo Finance
Mar-12-19 10:50AM  Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval Zacks
09:55AM  Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer Zacks
09:29AM  Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk PR Newswire
Mar-11-19 09:45AM  Is Amgen (AMGN) a Profitable Pick ForValue Investors Now? Zacks
Mar-10-19 05:19PM  Better Buy: Amgen vs. Biogen Motley Fool
Mar-08-19 04:32PM  Could A Patent Battle Force Sanofi To Snap Up This Biotech Stock? Investor's Business Daily
Mar-07-19 04:05PM  Amgen Announces 2019 Second Quarter Dividend PR Newswire
04:00PM  Amgen To Present At The Cowen and Company 39th Annual Healthcare Conference PR Newswire
Mar-06-19 04:00PM  New Data From Amgen To Be Presented At ACC.19 Continues To Build Evidence For Repatha® (evolocumab) Across Multiple Patient Populations PR Newswire
11:34AM  Lilly's Emgality Gets FDA Priority Review for Cluster Headache Zacks
09:05AM  Ligand Sells Promacta Rights for $827M, Updates '19 View Zacks
08:40AM  Here are three stocks that are trading at a discount CNBC Videos
08:16AM  3 Big Pharmas Trying to Pop the Rebate Bubble Motley Fool
07:56AM  Amgen Inc. (NASDAQ:AMGN): Poised For Long-Term Success? Simply Wall St.
07:42AM  Amgen Falls 3% Investing.com
06:28AM  Biotech Companies Slump Midday With FDA Chief Set to Leave Investing.com
Mar-05-19 06:57PM  U.S. FDA chief tough on e-cigs steps down in surprise resignation Reuters
08:42AM  Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda Zacks
07:30AM  New Research: Key Drivers of Growth for Marsh & McLennan Companies, Conagra Brands, Amgen, Emerson Electric, Polaris Industries, and Hologic Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-04-19 06:52PM  Salesforce co-CEO Benioff: Our revenue forecast 'far exceeds' what I expected CNBC Videos
10:05AM  AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab Zacks
Mar-01-19 02:18PM  Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales Zacks
09:33AM  Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales Zacks
Feb-28-19 04:00PM  Amgen Highlights Progress Of Innovative Early Oncology Pipeline With New Data At AACR 2019 PR Newswire
Feb-26-19 10:47AM  Sanofi/Regeneron Disagree With Jury Verdict in Amgen's Favor Zacks
03:32AM  Insulet (PODD) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 09:05PM  Xencor Inc (XNCR) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:48PM  Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug Reuters
05:28PM  UPDATE 1-Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug -report Reuters
04:56PM  Jury Upholds Amgen's Patents On Repatha® (evolocumab) PR Newswire
08:31AM  Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion Zacks
08:05AM  Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer GlobeNewswire
Feb-24-19 09:00AM  Better Buy: Amgen vs. Celgene Motley Fool
Feb-22-19 04:53PM  Amgen Starts Phase III Enrollment for Heart Failure Drug Zacks
08:00AM  The Top 5 Biotech Stocks Are Facing Growth Challenges Are Any Immune? Investor's Business Daily
Feb-21-19 10:18PM  Cytokinetics Inc (CYTK) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:24AM  The Zacks Analyst Blog Highlights: Walmart, Amgen, Honda, TransCanada and TransUnion Zacks
09:12AM  Merck Gets Priority Review for Keytruda in Third-Line SCLC Zacks
08:30AM  Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure PR Newswire
08:30AM  Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure GlobeNewswire
Feb-20-19 02:23PM  Top Analyst Reports for Walmart, Amgen and Honda Zacks
12:18PM  AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review Zacks
08:39AM  Merck's Keytruda Fails to Meet Endpoint in Liver Cancer Study Zacks
Feb-19-19 04:41PM  Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review Zacks
Feb-18-19 08:10AM  Merck Gets Priority Review for Keytruda Combo in Kidney Cancer Zacks
Feb-17-19 02:23PM  Behind the Cutting Edge Technology: The History of Amgen TheStreet.com
11:15AM  Is Amgen a Buy? Motley Fool
Feb-15-19 04:13PM  Amgen Inc. -- Moody's announces completion of a periodic review of ratings of Amgen Inc. Moody's
01:21PM  This Is One Company That Could Break Up Bristol-Celgene Deal Investor's Business Daily
08:01AM  [$$] WSJ Tax Guide 2019: The Drug Industry The Wall Street Journal
Feb-14-19 01:00PM  Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings Zacks
08:41AM  Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down Zacks
Feb-13-19 03:07PM  Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report Zacks
Feb-12-19 09:12AM  Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer Zacks
09:11AM  AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma Zacks
08:56AM  Sanofi/Regeneron Cut Price of PCSK9 Inhibitor Praluent by 60% Zacks
Feb-11-19 11:45AM  Regenerons 60% Price Cut Shows Heat Is Still on Drug Companies Barrons.com
07:18AM  Sanofi and Regeneron cut list price of cholesterol drug by 60 percent Reuters
07:00AM  Sanofi and Regeneron cut list price of cholesterol drug by 60 pct Reuters
06:11AM  2 Days Left To Cash In On Amgen Inc. (NASDAQ:AMGN) Dividend Simply Wall St.
Feb-08-19 08:03AM  Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View Zacks
Feb-07-19 05:52AM  Amgen Falls 3% Investing.com
Feb-06-19 09:37AM  Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down Zacks
Feb-05-19 09:02AM  Roche Submits sBLA to FDA for Label Expansion of Kadcyla Zacks
Feb-04-19 09:50AM  Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy Zacks
08:48AM  Pfizer's (PFE) New Lung Cancer Drug Vizimpro Gets CHMP Nod Zacks
Feb-03-19 10:09AM  The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs Benzinga
09:01AM  A War on High Drug Prices Could Boost Biosimilars Motley Fool
Feb-01-19 04:50PM  Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance Zacks
03:59PM  Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva Reuters
02:06PM  Why Amgen Should Buy Alexion Pharmaceuticals Barrons.com
08:00AM  Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics New Research Emphasizes Economic Growth GlobeNewswire
Jan-31-19 01:51PM  How 5 Goldman Stock Portfolios Are Racing Ahead of The Market Investopedia
12:48PM  Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y Zacks
Jan-30-19 06:04PM  3 Stocks Decline Wednesday GuruFocus.com
11:31AM  Stocks making the biggest moves midday: Tupperware, AT&T, Boeing, Apple & more CNBC
11:08AM  Biotech Giants Amgen and Biogen Fall on Earnings, Alzheimers News Barrons.com
08:46AM  Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid Zacks
08:12AM  The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Amgen and OncoCyte ACCESSWIRE
07:52AM  Stocks making the biggest moves premarket: Boeing, Apple, Alibaba, Tesla & more CNBC
07:23AM  Dow Jones Futures: Apple, AMD Drive Premarket Rally Investor's Business Daily
06:26AM  [$$] Stocks to Watch: Apple, AMD, eBay, Amgen, GameStop, Square The Wall Street Journal
06:02AM  Amgen Falls 6% Investing.com
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; and DaVita Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM
Harper Sean EEVP, Research & DevelopmentJul 16Sale195.711,525298,45856,082Jul 16 08:20 PM
Harper Sean EEVP, Research & DevelopmentJun 12Sale184.271,525281,01257,510Jun 12 07:07 PM
Harper Sean EEVP, Research & DevelopmentMay 14Sale174.101,525265,50359,035May 15 07:52 PM
Piacquad DavidSVP, Business DevelopmentMay 11Option Exercise54.7115,000820,65051,566May 15 07:55 PM
Harper Sean EEVP, Research & DevelopmentApr 12Sale172.681,525263,33756,788Apr 16 07:03 PM